Supplementary Table S4 from Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma

Tanner Michael Johanns; Elizabeth A.R. Garfinkle; Katherine E. Miller; Alexandra J. Livingstone; Kaleigh F. Roberts; Lakshmi P. Rao Venkata; Joshua L. Dowling; Michael R. Chicoine; Ralph G. Dacey; Gregory Joseph Zipfel; Albert H. Kim; Elaine R. Mardis; Gavin P. Dunn

doi:10.1158/1078-0432.31085038

Supplementary Table S4 from Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma

2026 Open access

Read full text

Authors: Tanner Michael Johanns, Elizabeth A.R. Garfinkle, Katherine E. Miller, Alexandra J. Livingstone, Kaleigh F. Roberts, Lakshmi P. Rao Venkata, Joshua L. Dowling, Michael R. Chicoine, Ralph G. Dacey, Gregory Joseph Zipfel, Albert H. Kim, Elaine R. Mardis

+1 more

Gavin P. Dunn

DOI: 10.1158/1078-0432.31085038

Cited by: 0

Abstract

Peptide sequences included in each subject's personalized NeoVax peptide vaccine

Fields of Study & Subjects

Glioma Diagnosis and Treatment Immunotherapy and Immune Responses vaccines and immunoinformatics approaches

Publication details

Publication date: 19 January 2026